Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

75.59 -0.84 (-1.10%)
Streaming Delayed Price Updated: 2:44 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,390,053
Open 78.13
Bid (Size) 75.53 (2)
Ask (Size) 75.59 (3)
Prev. Close 76.43
Today's Range 73.41 - 78.13
52wk Range 8.280 - 99.41
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
Via Benzinga
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount. 
Via InvestorPlace

Performance

YTD
+313.50%
+313.50%
1 Month
-4.92%
-4.92%
3 Month
+213.13%
+213.13%
6 Month
+689.85%
+689.85%
1 Year
+259.95%
+259.95%

More News

Read More
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Check Out What Whales Are Doing With VKTX
Via Benzinga
Is Viking Therapeutics Incredibly Undervalued?
Via The Motley Fool
Can This High-Flying Stock 10x in 10 Years?
Via The Motley Fool
Viking Therapeutics Unusual Options Activity
Via Benzinga
Looking At Viking Therapeutics's Recent Unusual Options Activity
Via Benzinga
Market Whales and Their Recent Bets on VKTX Options
Via Benzinga
1 Little-Known Vanguard Index Fund to Buy Before It Soars 50%, According to a Wall Street Analyst
Via The Motley Fool
3 Biotech Stocks to Buy on the Dip: April 2024
Via InvestorPlace
3 Millionaire-Maker Biotech Stocks
Via The Motley Fool
VKTX Stock Earnings: Viking Therapeutics Beats EPS for Q1 2024
Via InvestorPlace
Viking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEO
Via Benzinga
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
Via Benzinga
3 Biotech Stocks With Skyrocketing Potential: April 2024
Via InvestorPlace
3 Red-Hot Biotech Rockets Blasting Off in 2024
Via InvestorPlace
Topics Economy
Exposures Economy
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Via The Motley Fool
Better Buy: Pfizer vs. Viking Therapeutics
Via The Motley Fool
1 No-Brainer Vanguard Fund to Buy Right Now
Via The Motley Fool
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
Via InvestorPlace
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Via MarketBeat
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
Via InvestorPlace
Viking Therapeutics: Strong Results In Obesity
Via Talk Markets
3 Magnificent Stocks That Could Double or More by 2030
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.